Transmission of MDR and XDR tuberculosis in Shanghai, China

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Zhao, Ming ^a,b   Li, Xia ^b   Xu, Peng ^a,b   Shen, Xin ^a   Gui, Xiaohong ^a   Wang, Lili ^a   DeRiemer, Kathryn ^c   Mei, Jian ^a   Gao, Qian ^b  

^a Shanghai Railway Bureau Center for Disease Control and Prevention   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PROTIONAMIDE; RIFABUTIN; RIFAMPICIN; RIFAPENTINE; SPARFLOXACIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT HISTORY OF THERAPY; PREVALENCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 85006217298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004370     Document Type: Article

References (27)

1. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, et al. (2006) Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194: 479-485.
2. World Health Organization (2008) Anti-Tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance (Fourth global report) (WHO/HTM/TB/2008.394).
3. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, et al. (2006) Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368: 2142-2154.
4. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis andHIV in a rural area of South Africa. Lancet 368: 1575-1580.
5. World Health Organization (2007) XDR-TB: the facts-November 2007. Available: http://www.who.int/tb/challenges/xdr/facts-nov2007-en.pdf.
6. Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, et al. (2007) Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 45: 1290-1295.
7. Migliori GB, Ortmann J, Girardi E, Besozzi G, Lange C, et al. (2007) Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 13: 780-782.
8. Singh JA, Upshur R, Padayatchi N (2007) XDR-TB in South Africa: no time for denial or complacency. PLoS Med 4: e50.
9. Kent PT, Kubica GP (1985) Public health mycobacteriology: a guide for the level III laboratory. Atlanta, Ga.: U.S. Department of Health and Human Services/Public Health Service/Centers for Disease Control.
10. Canetti GFW, Khomenko A, Mahler HT, Menon NK, Mitchison DA (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ. pp 21-43.
11. World Health Organization (2001) Guidelines for drug susceptibility testing for second line anti-tuberculosis drugs for DOTS plus.(WHO/CDS/TB/2001.288): Geneva: the Organization.
12. (2006) Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 81: 430-432.
13. Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, et al. (2008) Extensively drug-resistant tuberculosis in california, 1993-2006. Clin Infect Dis 47: 450-457.
14. (1998) Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 2: 72-89.
15. Zhang L, Chen J, Shen X, Gui X, Mei J, et al. (2008) Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett 282: 22-31.
16. Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, et al. (2007) Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 87: 446-449.
17. Allix-Beguec C, Fauville-Dufaux M, Supply P (2008) Three-year populationbased evaluation of standardized mycobacterial interspersed repetitive-unitvariable-number tandem-repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 46: 1398-1406.
18. (2007) Extensively drug-resistant tuberculosis-United States, 1993-2006. MMWR Morb Mortal Wkly Rep 56: 250-253.
19. (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 55: 301-305.
20. Li X, Zhang Y, Shen X, Shen G, Gui X, et al. (2007) Transmission of drugresistant tuberculosis among treated patients in Shanghai, China. J Infect Dis 195: 864-869.
21. Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, et al. (2008) Exogenous Reinfection as a Cause of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Rural South Africa. J Infect Dis 198: 1582-1589.
22. Lew W, Pai M, Oxlade O, Martin D, Menzies D (2008) Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 149: 123-134.
23. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, et al. (2000) Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. Jama 283: 2537-2545.
24. DeRiemer K, Garcia-Garcia L, Bobadilla-del-Valle M, Palacios-Martinez M, Martinez-Gamboa A, et al. (2005) Does DOTS work in populations with drugresistant tuberculosis? Lancet 365: 1239-1245.
25. Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, et al. (2005) Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatientbased approach. Clin Infect Dis 40: 968-975.
26. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, et al. (2008) Comprehensive treatment of extensively drug-resistant tuberculosis.NEngl J Med 359: 563-574.
27. Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, et al. (2004) The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis 39: 1321-1328.